Archives

img-01

Quick Asia Regulatory Updates (November 2026)

Japan’s Ministry of Health, Labour and Welfare (MHLW) issued a set of notifications on September 30 to prepare drugmakers for the May 20, 2027 start of new legal rules on risk management plans (RMPs) under the amended Pharmaceuticals and Medical Devices (PMD)... Read More

img-01

Quick Korea Regulatory Updates (October 2026)

Korea’s Ministry of Food and Drug Safety (MFDS) has revised its regulation on post-market surveillance of medical devices by clarifying the criteria and required documentation for exempting rare disease devices with overseas use experience from Korea’s surveillance requirement. Post-market surveillance confirms the... Read More

img-01

Korea Regulatory Updates (August 2026)

Korea’s Ministry of Health and Welfare announced on June 30 a pilot program to speed up health insurance listing for rare disease treatments. The process will take only 100 days, down from 240 days. Under the pilot, cost-effectiveness assessments will happen after... Read More

img-01

Quick Asia Regulatory Updates (July 2026)

Korea’s Ministry of Food and Drug Safety (MFDS) revised its digital medical device labeling guidelines on June 10. The update follows industry difficulties after the Digital Medical Products Act took effect in January 2025. Key changes include a grace period permitting previous... Read More